Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection

Matthew J Hamilton, Alexa R. Weingarden, Michael J Sadowsky, Alexander Khoruts

Research output: Contribution to journalArticlepeer-review

438 Scopus citations

Abstract

OBJECTIVES: While fecal microbiota transplantation (FMT) is historically known to be an effective means to treat recurrent Clostridium difficile infection (CDI) refractory to standard antibiotic therapies, the procedure is rarely performed. At least some of the reasons for limited availability are those of practicality, including aesthetic concerns and costs of donor screening. The objective of this study was to overcome these barriers in our clinical FMT program. METHODS: We report clinical experience with 43 consecutive patients who were treated with FMT for recurrent CDI since inception of this program at the University of Minnesota. During this time, we simplified donor identification and screening by moving from patient-identified individual donors to standard volunteer donors. Material preparation shifted from the endoscopy suite to a standardized process in the laboratory, and ultimately to banking frozen processed fecal material that is ready to use when needed. RESULTS: Standardization of material preparation significantly simplified the practical aspects of FMT without loss of apparent efficacy in clearing recurrent CDI. Approximately 30% of the patients had underlying inflammatory bowel disease, and FMT was equally effective in this group. CONCLUSIONS: Several key steps in the standardization of donor material preparation significantly simplified the clinical practice of FMT for recurrent CDI in patients failing antibiotic therapy.

Original languageEnglish (US)
Pages (from-to)761-767
Number of pages7
JournalAmerican Journal of Gastroenterology
Volume107
Issue number5
DOIs
StatePublished - May 2012

Fingerprint Dive into the research topics of 'Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection'. Together they form a unique fingerprint.

Cite this